Additionally, some studies have found evidence that GLP-1–based therapies alleviate pathology associated with other diseases such as dementia in non-diabetic individuals, although there is controversy about the potential for these therapies in dementia treatment based on different findings, especially in human studies12,74. This evidence concerns the gene GCG and dementia.